UOC
IMGN

UBS O'Connor’s Immunogen Inc IMGN Stock Holding History

UBS O'Connor’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,915,452
Closed -$56.8M – 637
2023
Q4 		$56.8M Buy
+1,915,452
New +$38.1M 1.78% 8
2018
Q1 		– Sell
-200,000
Closed -$1.28M – 401
2017
Q4 		$1.28M Buy
+200,000
New +$1.23M 0.02% 226

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS O'Connor's IMGN Position: Q1 2024 in Review

UBS O'Connor sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,915,452 shares — an estimated $56.8M sold.

UBS O'Connor first reported a position in IMGN in Q4 2017 and held it in 2 quarters. The position peaked at $56.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • UBS O'Connor reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • UBS O'Connor sold 1,915,452 Immunogen Inc shares in Q1 2024, an estimated $56.8M.
  • UBS O'Connor first reported a position in Immunogen Inc in Q4 2017 and held it in 2 quarters.
  • UBS O'Connor's Immunogen Inc position peaked at $56.8M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.